Targeting Metastasis Through the Inhibition of Interleukin 6 and 8
Open Access
- 12 February 2019
- journal article
- editorial
- Published by Taylor & Francis in Breast Cancer Management
- Vol. 8 (1)
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Aging (U01AG060903)
This publication has 20 references indexed in Scilit:
- IL‐4 induces proliferation in prostate cancer PC3 cells under nutrient‐depletion stress through the activation of the JNK‐pathway and survivin up‐regulationJournal of Cellular Biochemistry, 2011
- Triple-Negative Breast CancerThe Cancer Journal, 2010
- Tumor Self-Seeding by Circulating Cancer CellsCell, 2009
- Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cellsOncogene, 2009
- Monoclonal antibody therapy of cancerNature Biotechnology, 2005
- Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast CancerJournal of Clinical Oncology, 2005
- Cancer genes and the pathways they controlNature Medicine, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- ABC of breast diseases: Breast cancer---epidemiology, risk factors, and geneticsBMJ, 2000